PALATIN TECHNOLOGIES, INC. Adjustments to Additional Paid in Capital, Other
PALATIN TECHNOLOGIES, INC. (PTN) reported Adjustments to Additional Paid in Capital, Other of $0 for the 12-month period ending 2021-06-30, per its 10-K filed 2021-09-28.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2021-09-28
- PALATIN TECHNOLOGIES, INC. adjustments to additional paid in capital, other for the quarter ending 2020-06-30 was $0.00.
- PALATIN TECHNOLOGIES, INC. adjustments to additional paid in capital, other for the quarter ending 2020-03-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. adjustments to additional paid in capital, other for the quarter ending 2019-12-31 was -$1.21M.
- PALATIN TECHNOLOGIES, INC. adjustments to additional paid in capital, other for the quarter ending 2019-09-30 was -$1.33M.
- PALATIN TECHNOLOGIES, INC. adjustments to additional paid in capital, other for fiscal 2021 was $0.00.
- PALATIN TECHNOLOGIES, INC. adjustments to additional paid in capital, other for fiscal 2020 was -$2.55M.
- PALATIN TECHNOLOGIES, INC. adjustments to additional paid in capital, other for fiscal 2019 was $0.00.
- PALATIN TECHNOLOGIES, INC. adjustments to additional paid in capital, other for fiscal 2018 was $0.00.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month | Adjustments to Additional Paid in Capital, Other 12 month as first filed |
|---|---|---|---|---|---|
| 2021-06-30 | $0.00 10-K · filed 2021-09-28 | ||||
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $0.00 derived: sum of 2 quarters · filed 2021-09-28 | -$1.21M derived: sum of 3 quarters · filed 2021-09-28 | -$2.55M 10-K · filed 2021-09-28 | $2.55M 10-K · filed 2020-09-25 |
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | -$1.21M derived: sum of 2 quarters · filed 2020-05-11 | -$2.55M 10-Q · filed 2020-05-11 | ||
| 2019-12-31 | -$1.21M 10-Q · filed 2020-02-10 | -$2.55M 10-Q · filed 2020-02-10 | |||
| 2019-09-30 | -$1.33M 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | $0.00 10-K · filed 2020-09-25 | ||||
| 2018-06-30 | $0.00 10-K · filed 2020-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |